Home/Pipeline/Bella-mu 1.4

Bella-mu 1.4

Cancer Vaccination (e.g., Breast Cancer)

Clinical Trial (Partner-led)Active

Key Facts

Indication
Cancer Vaccination (e.g., Breast Cancer)
Phase
Clinical Trial (Partner-led)
Status
Active
Company

About Uneedle

Uneedle is a specialized medical device developer creating ultra-sharp, ultra-precise silicon microneedles for targeted drug delivery. Its lead platforms are Bella-Vue for suprachoroidal injections in ophthalmology and Bella-mu for intradermal delivery, particularly for cancer vaccines. The company leverages semiconductor manufacturing processes to produce CE-marked and FDA-approved devices, positioning itself as a co-development and manufacturing partner for pharmaceutical companies. Its technology aims to transform complex injections into reliable, in-office procedures with reduced pain and improved precision.

View full company profile

Therapeutic Areas